- Home
- INTS vs MTEN Comparison
INTS vs MTEN Comparison
Compare INTS & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- MTEN
- Stock Information
- Founded
- INTS 2012
- MTEN 2015
- Country
- INTS United States
- MTEN China
- Employees
- INTS N/A
- MTEN N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- MTEN Building Products
- Sector
- INTS Health Care
- MTEN Industrials
- Exchange
- INTS Nasdaq
- MTEN Nasdaq
- Market Cap
- INTS 10.9M
- MTEN 82.6M
- IPO Year
- INTS 2023
- MTEN 2024
- Fundamental
- Price
- INTS $0.24
- MTEN $11.75
- Analyst Decision
- INTS Strong Buy
- MTEN
- Analyst Count
- INTS 4
- MTEN 0
- Target Price
- INTS $4.50
- MTEN N/A
- AVG Volume (30 Days)
- INTS 3.9M
- MTEN 59.0K
- Earning Date
- INTS 11-12-2025
- MTEN 10-18-2025
- Dividend Yield
- INTS N/A
- MTEN N/A
- EPS Growth
- INTS N/A
- MTEN N/A
- EPS
- INTS N/A
- MTEN N/A
- Revenue
- INTS N/A
- MTEN $10,120,257.00
- Revenue This Year
- INTS N/A
- MTEN N/A
- Revenue Next Year
- INTS N/A
- MTEN N/A
- P/E Ratio
- INTS N/A
- MTEN N/A
- Revenue Growth
- INTS N/A
- MTEN 23.03
- 52 Week Low
- INTS $0.19
- MTEN $3.20
- 52 Week High
- INTS $4.18
- MTEN $26.03
- Technical
- Relative Strength Index (RSI)
- INTS 36.68
- MTEN 43.04
- Support Level
- INTS $0.22
- MTEN $11.47
- Resistance Level
- INTS $0.25
- MTEN $12.75
- Average True Range (ATR)
- INTS 0.02
- MTEN 0.84
- MACD
- INTS -0.00
- MTEN 0.07
- Stochastic Oscillator
- INTS 29.27
- MTEN 56.92
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.